Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Return on Sales (2019 - 2025)

Burning Rock Biotech has reported Return on Sales over the past 7 years, most recently at 0.0% for Q4 2025.

  • For Q4 2025, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM value through Dec 2025 reached 0.0%, up 1.0%, while the annual FY2025 figure was 0.0%, 1.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.0% at Burning Rock Biotech, up from 0.0% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.0% in Q2 2025 and troughed at 0.02% in Q2 2022.
  • A 5-year average of 0.01% and a median of 0.01% in 2023 define the central range for Return on Sales.
  • Biggest five-year swings in Return on Sales: fell -1bps in 2021 and later grew 1bps in 2023.
  • Year by year, Return on Sales stood at 0.02% in 2021, then increased by 13bps to 0.01% in 2022, then rose by 11bps to 0.01% in 2023, then soared by 58bps to 0.01% in 2024, then soared by 81bps to 0.0% in 2025.
  • Business Quant data shows Return on Sales for BNR at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.